Zhengyu Feng

Zhengyu Feng, Ph.D., is an associate in the Washington, D.C. office and is a member of the firm’s Intellectual Property Practice Group.

In General.  Dr. Feng earned his B.S. in Biochemistry from Fudan University, Shanghai, People’s Republic of China in 1995 and his Ph.D. in Medical Sciences/Microbiology from the University of Nebraska Medical Center in 2002. His doctoral dissertation focused on the genetic and biochemical characterization of microbial drug resistance. Before law school, Feng was a postdoctoral fellow at the University of Texas-Austin and his research included work in the fields of molecular biology, genetics, microbiology, and cell biology. He received his J.D. from the University of Houston Law Center in 2007.

Feng is a native speaker of Mandarin Chinese.



From the Blog

Privately Held Medical Device and Drug Companies Face Unique Sunshine Act Challenges

As widely reported, the Centers for Medicare and Medicaid Services (“CMS”) recently issued regulations implementing the Sunshine Act provisions of the Affordable Care Act. ...

What Goes Up…Must Come Down: Viagra patent invalidated by Canadian Supreme Court

Pfizer and Teva have been fighting a legal battle over Pfizer’s patent for Viagra in Canada.  The first shot was fired when Novopharm Limited,...

The Perils and Promise of 3D Printing: Are DIY Life Sciences in Your Future?

With news that 3D printing (without question one of the coolest technologies to come down the road in quite some time) can be used...